Design of Experiments for Biostats and AI/ML
Design of Experiments for Biostats and AI/ML
This series focuses on how studies are structured, how comparisons are made, and how evidence becomes more or less credible depending on design choices.
The goal is to connect classical study-design thinking with modern biostatistics, AI/ML evaluation, and applied decision-making. Good analysis does not begin with a model. It begins with a design.
This series treats design as the architecture of evidence: the part of the work that determines what can be learned, what remains ambiguous, and how strongly findings can support action.
Topics in This Series
This series includes:
- Randomized controlled trials
- Observational study designs
- Cross-sectional study design
- Longitudinal study design
- Sample size and power analysis
- Stratification and randomization techniques
- Blinding and placebo controls
- Adaptive study designs
- Pragmatic trials
- Quasi-experimental designs
What This Series Is For
This series is intended for readers who want to think more clearly about how studies are built before results are analyzed.
It is especially useful for:
- applied statisticians
- clinical and health-services researchers
- analysts interpreting evidence from different study types
- data scientists working with observational or quasi-experimental data
- readers who want stronger intuition about validity, comparison, and bias control
How to Read This Series
A natural way to read this series is to move from foundational study types into increasingly complex design strategies.
One useful path is:
Core study structures
- Randomized controlled trials
- Observational study designs
- Cross-sectional study design
- Longitudinal study design
Design quality and control of variation
- Sample size and power analysis
- Stratification and randomization techniques
- Blinding and placebo controls
Flexible and practice-oriented designs
- Adaptive study designs
- Pragmatic trials
- Quasi-experimental designs
This sequence moves from basic design categories, to mechanisms for improving internal validity, to design approaches that respond to real-world operational constraints.
Why This Series Matters
Many analytic disagreements are actually design disagreements.
Questions such as:
- What comparison is being made?
- Who entered the study and why?
- What sources of bias were controlled, and which were left open?
- How much can a result support causal interpretation?
- When does a real-world design answer the practical question better than an idealized one?
are fundamentally design questions.
This is why design remains central not only in biostatistics, but also in AI/ML evaluation, policy analysis, and real-world evidence generation.
Relationship to the Broader Blog
This series connects directly to several others across the site.
It pairs especially well with:
Where to Go Next
Readers who complete this series may want to continue with:
- Advanced Topics in Applied Statistics for AI and Clinical Decision-Making
- Real-World Evidence
- Toolkit
Return to the Series Hub.